- Home
- CHSCP vs ORMP Comparison
CHSCP vs ORMP Comparison
Compare CHSCP & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHSCP
- ORMP
- Stock Information
- Founded
- CHSCP N/A
- ORMP 2002
- Country
- CHSCP United States
- ORMP United States
- Employees
- CHSCP N/A
- ORMP N/A
- Industry
- CHSCP Farming/Seeds/Milling
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- CHSCP Industrials
- ORMP Health Care
- Exchange
- CHSCP Nasdaq
- ORMP Nasdaq
- Market Cap
- CHSCP N/A
- ORMP N/A
- IPO Year
- CHSCP N/A
- ORMP N/A
- Fundamental
- Price
- CHSCP $27.78
- ORMP $2.16
- Analyst Decision
- CHSCP
- ORMP Hold
- Analyst Count
- CHSCP 0
- ORMP 1
- Target Price
- CHSCP N/A
- ORMP N/A
- AVG Volume (30 Days)
- CHSCP N/A
- ORMP 61.6K
- Earning Date
- CHSCP N/A
- ORMP 08-15-2025
- Dividend Yield
- CHSCP N/A
- ORMP N/A
- EPS Growth
- CHSCP N/A
- ORMP N/A
- EPS
- CHSCP N/A
- ORMP N/A
- Revenue
- CHSCP N/A
- ORMP $2,000,000.00
- Revenue This Year
- CHSCP N/A
- ORMP N/A
- Revenue Next Year
- CHSCP N/A
- ORMP N/A
- P/E Ratio
- CHSCP N/A
- ORMP N/A
- Revenue Growth
- CHSCP N/A
- ORMP 196.74
- 52 Week Low
- CHSCP N/A
- ORMP $1.82
- 52 Week High
- CHSCP N/A
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- CHSCP 54.03
- ORMP 49.24
- Support Level
- CHSCP $27.69
- ORMP $2.09
- Resistance Level
- CHSCP $27.99
- ORMP $2.22
- Average True Range (ATR)
- CHSCP 0.26
- ORMP 0.09
- MACD
- CHSCP 0.02
- ORMP -0.00
- Stochastic Oscillator
- CHSCP 53.49
- ORMP 55.26
About CHSCP CHS Inc. 8% Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).